← Leaderboards
Janet F. Eary
University Of Washington
$6,843,987
Attributed
$6,843,987
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$12,471,375 · 6
By mechanism
P01$6,933,144 · 4
R01$5,038,231 · 1
N01$500,000 · 1
Top collaborators
- Kenneth A. Krohn6 shared
Most similar at University Of Washington
Same institution · by research overlap
- Kenneth A. Krohn$5,749,811
- Jeanne Meyers Link$5,252,906
- Alexander M Spence$1,477,699
- Vasily L. Yarnykh$3,068,790
- Michael G McDonell$9,663,091
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsPositron-Emission TomographyResponseTumorUptakeTissuesChemotherapyImageNeoadjuvant TherapyNeoplasm MetastasisMalignant NeoplasmsBioimaging /Biomedical ImagingSarcomaCancer PatientEvaluationFluorodeoxyglucose Positron Emission TomographyProgramsSiteObservational StudyRadiopharmaceuticalsEffectivenessResistanceAggressive Behavior
Grant awards (35)
Acquired Multi-Drug Resistance$114,888
P01 · FY2015 · CA · contact PI
Molecular Imaging of Cancer and Its Response to Therapy$108,691
P01 · FY2015 · CA
Molecular Imaging of Cancer and Its Response to Therapy$1,328,882
P01 · FY2014 · CA
Acquired Multi-Drug Resistance$112,429
P01 · FY2014 · CA · contact PI
Molecular Imaging of Cancer and Its Response to Therapy Diversity Supplement$108,691
P01 · FY2014 · CA
Molecular Imaging of Cancer and Its Response to Therapy$1,292,896
P01 · FY2013 · CA
Acquired Multi-Drug Resistance$110,203
P01 · FY2013 · CA · contact PI
Molecular Imaging of Cancer and Its Response to Therapy$1,378,841
P01 · FY2012 · CA
Acquired Multi-Drug Resistance$118,254
P01 · FY2012 · CA · contact PI
Molecular Imaging of Cancer and Its Response to Therapy$1,409,387
P01 · FY2011 · CA
PET in Sarcoma - A Clinical Trial$344,360
R01 · FY2011 · CA · contact PI
PET in Sarcoma - A Clinical Trial$500,651
R01 · FY2010 · CA · contact PI
PET in Sarcoma - A Clinical Trial$631,488
R01 · FY2009 · CA · contact PI
Lymphoma and Its Response to Treatment$139,731
P01 · FY2008 · CA · contact PI
PET in Sarcoma - A Clinical Trial$26,940
R01 · FY2008 · CA · contact PI
PET in Sarcoma - A Clinical Trial$506,555
R01 · FY2007 · CA · contact PI
EARLY CLINICAL TRIALS OF IMAGING AGENTS$500,000
N01 · FY2007 · CA · contact PI
Lymphoma and Its Response to Treatment$140,882
P01 · FY2007 · CA · contact PI
PET in Sarcoma - A Clinical Trial$527,153
R01 · FY2006 · CA · contact PI
Lymphoma and Its Response to Treatment$98,777
P01 · FY2006 · CA · contact PI
PET IN SARCOMA--A CLINICAL TRIAL$164,999
R01 · FY2005 · CA
Lymphoma and Its Response to Treatment$96,300
P01 · FY2005 · CA
PET IN SARCOMA--A CLINICAL TRIAL$495,236
R01 · FY2004 · CA
Lymphoma and Its Response to Treatment$93,494
P01 · FY2004 · CA
PET IN SARCOMA--A CLINICAL TRIAL$480,812
R01 · FY2003 · CA
PET IN SARCOMA--A CLINICAL TRIAL$466,810
R01 · FY2002 · CA
CORE--RADIOCHEMISTRY$0
P01 · FY2002 · CA
QUANTITATION OF TUMOR GROWTH IN NOVEL CANCER THERAPIES$0
P01 · FY2002 · CA
PET IN SARCOMA--A CLINICAL TRIAL$453,214
R01 · FY2001 · CA
QUANTITATION OF TUMOR GROWTH IN NOVEL CANCER THERAPIES$0
P01 · FY2001 · CA
CORE--RADIOCHEMISTRY$0
P01 · FY2001 · CA
CORE--RADIOCHEMISTRY$0
P01 · FY2001 · CA
PET IN SARCOMA--A CLINICAL TRIAL$440,013
R01 · FY2000 · CA
QUANTITATION OF TUMOR GROWTH IN NOVEL CANCER THERAPIES$280,798
P01 · FY2000 · CA
CORE--RADIOCHEMISTRY$0
P01 · FY2000 · CA